is glp3 retatrutide (GLP-3) – Y&P Labs GLP-1? Helpful. GLP-2? Amazing. GLP-3?

Consistent adherence to the full schedule produces the best long-term outcomes.

Cost and Accessibility: Currently, the production cost of peptide drugs is relatively high, but the long-acting properties of retasopeptide may reduce the frequency of medication and improve patient compliance

Researchers are actively studying the potential for GLP-1s to help with other health concerns including aspects of brain health something McIntyre says hes excited about

Currently, the medication is being tested in phase 3 trials, and FDA approval may come as early as 2027

Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, ONeil J, et al

Grassi G, Mark A, Esler M